Neuromelanin-Sensitive MRI: A Biomarker for Treatment-Resistant Schizophrenia?

Luke J Vano¹, Mattia Veronese¹, Robert A McCutcheon¹+1

• ¹Department of Psychosis Studies, Institute of Psychiatry, Psychology, and Neuroscience, King's College London (Vano, McCutcheon, Howes); Psychiatric Imaging Group, MRC Laboratory of Medical Sciences, Hammersmith Hospital, London (Vano, Howes); Institute of Clinical Sciences, Faculty of Medicine, Imperial College London, London (Vano, Howes); South London and Maudsley NHS Foundation Trust, London (Vano, Howes); Department of Neuroimaging, King's College London (Veronese); Department of Information Engineering, University of Padua, Padua, Italy (Veronese); Department of Psychiatry, University of Oxford, Oxford, U.K. (McCutcheon); Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, U.K. (McCutcheon).